| [1] |
Wang Jiuxue, Li Na, Jin Wei, Wang Shuo, Chang Yajun, Wang Tianjun.
Correlation between serum uric acid, homocysteine and cystatin C levels with motor symptoms and cognitive function in Parkinson's disease patients
[J]. Clinical Focus, 2024, 39(2): 125-129.
|
| [2] |
.
[J]. Clinical Focus, 2023, 38(9): 845-850.
|
| [3] |
.
[J]. Clinical Focus, 2023, 38(9): 855-858.
|
| [4] |
.
[J]. Clinical Focus, 2023, 38(2): 189-192.
|
| [5] |
Li Wenjun, Zhang Ce, Liu Junyan.
Improving circulation aggravates the orthostatic hypotension in a patient with Parkinson's disease: A case report
[J]. Clinical Focus, 2022, 37(10): 934-937.
|
| [6] |
.
[J]. Clinical Focus, 2022, 37(5): 463-466.
|
| [7] |
Guo Chang, Shen Huinan, Sun Yimeng, Wang Dongyu.
Correlation between blood lipid and homocysteine and cognitive impairment in Parkinson's disease
[J]. Clinical Focus, 2022, 37(2): 128-132.
|
| [8] |
Zhao Hang;Ge Hanming;Liang Zhanhua;Wang Yan.
Correlation analysis of individualized treatment compliance and disease progression in patients with Parkinson disease
[J]. Clinical Focus, 2015, 30(5): 499-502.
|
| [9] |
SUN Lin-juan;XU Sheng-li;ZHOU Ming;MAO Li-jun;CHEN Biao.
Protection of cysteamine on 1-methy1-4-phenylpyridinium induced SH-SY5Y in Parkinson's disease cell model by antioxidant
[J]. Clinical Focus, 2014, 29(7): 740-743.
|
| [10] |
SUN Lin-juan;MAO Li-jun;XU Sheng-li;ZHOU Ming;CHEN Biao.
Protection of cysteamine on dopaminergic neurons in Parkinson disease mice model by antioxidant
[J]. Clinical Focus, 2013, 28(2): 181-0.
|
| [11] |
.
[J]. Clinical Focus, 2012, 27(15): 1359-0.
|
| [12] |
ZENG Wen-jing;ZHANG Xiao-ying;LI Yan-yun;LIU Yan;LI Yan.
Relationship between polymorphism of monoamine oxidase B gene and Parkinson disease in Xinjiang Uygurs
[J]. Clinical Focus, 2012, 27(9): 764-766.
|
| [13] |
.
[J]. CLINICAL FOCUS, 2011, 26(10): 888901-0.
|
| [14] |
.
[J]. CLINICAL FOCUS, 2011, 26(5): 400-0.
|
| [15] |
.
[J]. CLINICAL FOCUS, 2010, 25(21): 1931-0.
|
